Skip to main content

Table 2 VHL mutational status in RCC patients

From: Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity

Exon Mutation Mutation type
3 c. 565C > T; p.E189X Nonsense
3 c.481 C > T; p.R161X Nonsense
1 c.203C > A; p.S68X Nonsense
2 c.345_349delCCTTT; p.G114 fs*15 Frameshift
1 c.162 insG; p. M54 fs*12 Frameshift
2 c.450delT; p.N150 fs*9 Frameshift
1 c. 203_209delCGCGCGA; p. S68 fs*89 Frameshift
1 c.215_222delCCAGGTC; p. E70fs*57 Frameshift
3 c.502_505delAGCC; p. S168 fs*1 Frameshift
2 c.391_394delAACC; p.N131 fs*26 Frameshift
3 c.638_639insT; p. D213fs*2 Frameshift
1 c.199delA; p.N67Tfs*97 Frameshift
1 c.306_314delGCCTGGCA p.P102Pfs*27 Frameshift
2 c.411_413 insGT; p. V137Cfs*22 Frameshift
1 c.339_340delAG; p.G114 fs*17 Frameshift
2 c.444delT; p.F148 fs*11 Frameshift
1 c.1101delA; p.V87 fs*47 Frameshift
1 c.340G > T; p.G114C Missense
1 c.234 T > G; p.N78 K Missense
3 c.488 T > A; p.L163H Missense
1 c.240 T > A; p.S80R Missense
1 c.506C > T; p. L169P Missense
2 c.602 T > C; p.L201R Missense
1 c.194C > T p.S65 L Missense
2 c.IVS2 + 2 T > C Splicing
2 c.IVS1–1 G > C Splicing